SHR3824
SHR3824 is a pharmaceutical drug with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient
Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes
The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients
Clinical Trials (10)
Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient
Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes
The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients
The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients
The PK/PD Study of Multiple Dose of SHR3824 in Healthy Volunteers
The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers
Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus Patients
Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10